Prev：Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways(A01020-4.1)
Next：NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy(A01020-2.91)
Welcome any form of communications, and better service will be provided here.
Bldg C17, Optics Valley International Biomedicine Park, Wuhan, China. 430223